A Multibasic Cleavage Site in the Spike Protein of SARS-CoV-2 Is Essential for Infection of Human Lung Cells

Hoffmann, Markus, Kleine-Weber, Hannah, Pöhlmann, Stefan·2020·Molecular Cell
DOI 10.1016/j.molcel.2020.04.022

Cited by (1,004)

Items 301–400 of 1,004

  1. Pharmacological Significance of Hesperidin and Hesperetin, Two Citrus Flavonoids, as Promising Antiviral Compounds for Prophylaxis Against and Combating COVID-19
    Pawan Kumar Agrawal, Chandan Agrawal, Gerald Blunden · 2021 · Natural Product Communications
  2. CD169-mediated restrictive SARS-CoV-2 infection of macrophages induces pro-inflammatory responses
    Sallieu Jalloh, Judith Olejnik, Jacob L. Berrigan, Annuurun Nisa, Ellen L. Suder, Hisashi Akiyama, Maohua Lei, Sita Ramaswamy, Sanjay Tyagi, Yuri Bushkin et al. · 2022 · PLoS Pathogens
  3. Drug Combinations as a First Line of Defense against Coronaviruses and Other Emerging Viruses
    White, Judith M., Schiffer, Joshua T., Bender Ignacio, Rachel A., Xu, Shuang, Kainov, Denis, Ianevski, Aleksandr, Aittokallio, Tero, Frieman, Matthew, Olinger, Gene G., Polyak, Stephen J. · 2021 · mBio
  4. Genetic Spectrum and Distinct Evolution Patterns of SARS-CoV-2
    Sheng Liu, Jikui Shen, Shuyi Fang, Kailing Li, Juli Liu, Lei Yang, Chang‐Deng Hu, Jun Wan · 2020 · Frontiers in Microbiology
  5. Safety, immunogenicity, and protection provided by unadjuvanted and adjuvanted formulations of a recombinant plant-derived virus-like particle vaccine candidate for COVID-19 in nonhuman primates
    Stéphane Pillet, Prabhu S. Arunachalam, Guadalupe Andreani, Nadia Golden, Jane A. Fontenot, Pyone P. Aye, Katharina Röltgen, Gabrielle Lehmicke, Philipe Gobeil, Charlotte Dubé et al. · 2022 · Cellular and Molecular Immunology
  6. Ribavirin shows antiviral activity against SARS-CoV-2 and downregulates the activity of TMPRSS2 and the expression of ACE2 in vitro
    Mehmet Altay Ünal, Ceylan Verda Bitirim, Gökçe Yağmur Summak, Sidar Bereketoğlu, İnci Cevher Zeytin, Ömür Beşbinar, Cansu Gürcan, Dunya Aydos, Ezgi Göksoy, Ebru Kocakaya et al. · 2021 · Canadian Journal of Physiology and Pharmacology
  7. Term Human Placental Trophoblasts Express SARS-CoV-2 Entry Factors ACE2, TMPRSS2, and Furin
    Yingshi Ouyang, Tarique Rajasaheb Bagalkot, Wendy Fitzgerald, Elena Sadovsky, Tianjiao Chu, Ana Martínez-Marchal, Miguel A. Brieño‐Enríquez, Emily J. Su, Leonid B Margolis, Alexander D. Sorkin et al. · 2021 · mSphere
  8. Brain Mechanisms of COVID-19-Sleep Disorders
    Oxana V. Semyachkina-Glushkovskaya, Aysel Mamedova, Valeria Telnova, Maria Klimova, Elena I. Saranceva, Vasily Ageev, Tingting Yu, Dan Yan Zhu, Thomas Penzel, Jürgen Kurths · 2021 · International Journal of Molecular Sciences
  9. The circadian clock component BMAL1 regulates SARS-CoV-2 entry and replication in lung epithelial cells
    Xiaodong Alan Zhuang, Senko Tsukuda, Florian Wrensch, Peter A. C. Wing, Mirjam Schilling, James M. Harris, Helene Borrmann, Sophie B. Morgan, Jennifer Cane, Laurent Mailly et al. · 2021 · iScience
  10. Metformin to decrease COVID-19 severity and mortality: Molecular mechanisms and therapeutic potential
    Oleksandr Kamyshnyi, V. M. Matskevych, Tetyana Lenchuk, Olha M. Strilbytska, Kenneth B. Storey, Oleh V. Lushchak · 2021 · Biomedicine & Pharmacotherapy
  11. The MEK1/2-inhibitor ATR-002 efficiently blocks SARS-CoV-2 propagation and alleviates pro-inflammatory cytokine/chemokine responses
    André Schreiber, Dorothee Viemann, Jennifer Schöning, Sebastian Schloer, Angeles Mecate‐Zambrano, Linda Brunotte, Aileen Faist, Michael Schöfbänker, Eike Roman Hrincius, Helen Hoffmann et al. · 2022 · Cellular and Molecular Life Sciences
  12. An overview of anti-SARS-CoV-2 and anti-inflammatory potential of baicalein and its metabolite baicalin: Insights into molecular mechanisms
    Biswanath Dinda, Manikarna Dinda, Subhajit Dinda, Utpal Chandra De · 2023 · European Journal of Medicinal Chemistry
  13. The inorganic polymer, polyphosphate, blocks binding of SARS-CoV-2 spike protein to ACE2 receptor at physiological concentrations
    Meik Neufurth, Xiaohong Wang, Emad Tolba, Ingo Lieberwirth, Shunfeng Wang, Heinz Christoph Schröder, Wernér E.G. Müller · 2020 · Biochemical Pharmacology
  14. Severe Acute Respiratory Syndrome Coronavirus 2, COVID-19, and the Renin-Angiotensin System
    Matthew A. Sparks, Andrew Michael South, Andrew D. Badley, Carissa Marrie Baker-Smith, DANIEL C. BATLLE, Biykem Bozkurt, Roberto Cattaneo, Steven D. Crowley, Louis J. Dell’Italia, Andria L. Ford et al. · 2020 · Hypertension
  15. SARS-CoV-2 and influenza: a comparative overview and treatment implications
    Laura D. Manzanares, Oscar Medina Contreras · 2020 · Boletín Médico del Hospital Infantil de México
  16. Severe acute respiratory syndrome coronavirus 2 may be an underappreciated pathogen of the central nervous system
    Syed Benazir Alam, Steven D. Willows, Marianna Kulka, Jagdeep K. Sandhu · 2020 · European Journal of Neurology
  17. Sphingolipids as Modulators of SARS-CoV-2 Infection
    Kid Törnquist, Muhammad Yasir Asghar, Vignesh Srinivasan, Laura Korhonen, Dan Lindholm · 2021 · Frontiers in Cell and Developmental Biology
  18. Endoplasmic Reticulum Chaperones in Viral Infection: Therapeutic Perspectives
    Évelyne Kohli, Sébastien Causse, Valentin Baverel, Laurence Dubrez, Natalia Borges-Bonan, Oleg N. Demidov, Carmen Garrido · 2021 · Microbiology and Molecular Biology Reviews
  19. Potential Anti-COVID-19 Therapeutics that Block the Early Stage of the Viral Life Cycle: Structures, Mechanisms, and Clinical Trials
    Rami A. Al‐Horani, Srabani Kar, Kholoud F. Aliter · 2020 · International Journal of Molecular Sciences
  20. Classical and alternative receptors for SARS‐CoV‐2 therapeutic strategy
    Siti Fathiah Masre, Nurul Farhana Jufri, Farah Wahida Ibrahim, Sayyidi Hamzi Abdul Raub · 2020 · Reviews in Medical Virology
  21. SARS-CoV-2 Omicron variants: burden of disease, impact on vaccine effectiveness and need for variant-adapted vaccines
    Shanti Pather, Shabir Ahmed Madhi, Benjamin John Cowling, Paul A. H. Moss, Jeremy P. Kamil, Sandra Ciesek, Alexander Muik, Özlem Türeci · 2023 · Frontiers in Immunology
  22. Increased infections, but not viral burden, with a new SARS-CoV-2 variant
    Walker, A. Sarah, Vihta, Karina-Doris, Gethings, Owen, Pritchard, Emma, Jones, Joel, House, Thomas, Bell, Iain, Bell, John I, Newton, John N, Farrar, Jeremy et al. · 2021
  23. In-silico design of a potential inhibitor of SARS-CoV-2 S protein
    Grijesh Jaiswal, Veerendra Kumar · 2020 · PLoS ONE
  24. A New Immortalized Human Alveolar Epithelial Cell Model to Study Lung Injury and Toxicity on a Breathing Lung-On-Chip System
    Arunima Sengupta, Nuria Roldán, Mirjam Kiener, Laurène Froment, Giulia Raggi, Théo Imler, Lea Lara De Maddalena, Aude Rapet, Tobias May, Patrick Carius et al. · 2022 · Frontiers in Toxicology
  25. Co-existence and co-infection of influenza A viruses and coronaviruses: Public health challenges
    Jing Yang, Yuhuan Gong, Chunge Zhang, Ju Sun, Gary Wong, Weifeng Shi, Wenjun Liu, George F. Gao, Yuhai Bi · 2022 · The Innovation
  26. Supervised molecular dynamics for exploring the druggability of the SARS-CoV-2 spike protein
    Giuseppe Deganutti, Filippo Prischi, Christopher Arthur Reynolds · 2020 · Journal of Computer-Aided Molecular Design
  27. A monoclonal antibody against staphylococcal enterotoxin B superantigen inhibits SARS-CoV-2 entry in vitro
    Mary Hongying Cheng, Rebecca A. Porritt, Magali Noval Rivas, James Krieger, Asli Beyza Ozdemir, Gustavo Garcia, Vaithilingaraja Arumugaswami, Bettina C. Fries, Moshe Arditi, İvet Bahar · 2021 · Structure
  28. Pulmonary Toxicity and Inflammatory Response of Vape Cartridges Containing Medium-Chain Triglycerides Oil and Vitamin E Acetate: Implications in the Pathogenesis of EVALI
    Thivanka Muthumalage, Joseph H. Lucas, Qixin Wang, Thomas W. Lamb, Matthew McGraw, Irfan Rahman · 2020 · Toxics
  29. Inactivation of various variant types of SARS-CoV-2 by indoor-light-sensitive TiO2-based photocatalyst
    Ryuichi Nakano, Akira Yamaguchi, Kayano Sunada, Takeshi Nagai, Akiyo Nakano, Yuki Suzuki, Hisakazu Yano, Hitoshi Ishiguro, Masahiro Miyauchi · 2022 · Scientific Reports
  30. Preclinical evaluation of a SARS-CoV-2 mRNA vaccine PTX-COVID19-B
    Liu, Jun, Budylowski, Patrick, Samson, Reuben, Griffin, Bryan D., Babuadze, Giorgi, Rathod, Bhavisha, Colwill, Karen, Abioye, Jumai A., Schwartz, Jordan A., Law, Ryan et al. · 2022 · Science Advances
  31. Protein expression of angiotensin‐converting enzyme 2, a SARS‐CoV ‐2‐specific receptor, in fetal and placental tissues throughout gestation: new insight for perinatal counseling
    Valentine Faure‐Bardon, Pierre Isnard, N. Roux, Marianne Leruez‐Ville, Thierry Jo Molina, Bettina Bessières, Yves G. Ville · 2020 · Ultrasound in Obstetrics and Gynecology
  32. Robust and persistent SARS-CoV-2 infection in the human intestinal brush border expressing cells
    Sun-Hee Lee, Gun Young Yoon, Jinjong Myoung, Seong‐Jun Kim, Dae‐Gyun Ahn · 2020 · Emerging Microbes & Infections
  33. Placental response to maternal SARS-CoV-2 infection
    Mirella Mourad, Taylor Jacob, Elena Sadovsky, Shai Bejerano, Glicella Salazar-De Simone, Tarique Rajasaheb Bagalkot, Jason E Zucker, Michael T. Yin, Jennifer Y. Chang, Lihong Liu et al. · 2021 · Scientific Reports
  34. Pathogenesis‐directed therapy of 2019 novel coronavirus disease
    Charles W. Stratton, Yi‐Wei Tang, Hongzhou Lu · 2020 · Journal of Medical Virology
  35. Multifunctional angiotensin converting enzyme 2, the SARS-CoV-2 entry receptor, and critical appraisal of its role in acute lung injury
    Murat Öz, Dietrich Ernst Lorke · 2021 · Biomedicine & Pharmacotherapy
  36. SARS-CoV-2 variants reveal features critical for replication in primary human cells
    Marie O. Pohl, Idoia Busnadiego, Verena Kufner, Irina Glas, Umut Karakus, Stefan Schmutz, Maryam Zaheri, Irène A. Abela, Alexandra Trkola, Michael Huber et al. · 2021 · PLoS Biology
  37. Precision therapeutic targets for COVID-19
    Zachary A. Krumm, Grace M. Lloyd, Connor P. Francis, Lith H. Nasif, Duane A. Mitchell, Todd Eliot Golde, Benoit I. Giasson, Yuxing Xia · 2021 · Virology Journal
  38. Intrinsic D614G and P681R/H mutations in SARS-CoV-2 VoCs Alpha, Delta, Omicron and viruses with D614G plus key signature mutations in spike protein alters fusogenicity and infectivity
    Ritika Khatri, Gazala Siddqui, Srikanth Sadhu, Vikas Maithil, Preeti Vishwakarma, Bharat Lohiya, Abhishek Goswami, Shubbir Ahmed, Amit Awasthi, Sweety Samal · 2022 · Medical Microbiology and Immunology
  39. Expression and characterization of SARS-CoV-2 spike proteins
    Jeffrey M. Schaub, Chia-Wei Chou, Hung-Che Kuo, Kamyab Javanmardi, Ching-Lin Hsieh, J. Goldsmith, Andrea M. DiVenere, Kevin C. Le, D. Wrapp, P. O. Byrne et al. · 2021 · Nature Protocols
  40. Integrated Biophysical Modeling of the SARS-CoV-2 Spike Protein Binding and Allosteric Interactions with Antibodies
    Gennady M. Verkhivker, Luisa Di Paola · 2021 · The Journal of Physical Chemistry B
  41. Millisecond dynamic of SARS‐CoV‐2 spike and its interaction with ACE2 receptor and small extracellular vesicles
    Keesiang Lim, Goro Nishide, Takeshi Yoshida, Takahiro Watanabe‐Nakayama, Akiko Kobayashi, Masaharu Hazawa, Rikinari Hanayama, Toshio Ando, Richard Wing-Chuen Wong · 2021 · Journal of Extracellular Vesicles
  42. SARS-CoV-2 spike protein: structure, viral entry and variants
    Bing Chen, Michael Farzan, Hyeryun Choe · 2025 · Nature Reviews Microbiology
  43. Unusual Features of the SARS-CoV-2 Genome Suggesting Sophisticated Laboratory Modification Rather Than Natural Evolution and Delineation of Its Probable Synthetic Route
    Yan, Li-Meng, Shu Kang, Shanchang Hu · 2020 · Zenodo (CERN European Organization for Nuclear Research)
  44. Genomic diversity and evolution, diagnosis, prevention, and therapeutics of the pandemic COVID-19 disease
    M. Nazmul Hoque, Abed Chaudhury, Md. Abdul Mannan Akanda, M. Anwar Hossain, Tofazzal Islam · 2020 · PeerJ
  45. Natural Transmission of Bat-like Severe Acute Respiratory Syndrome Coronavirus 2 Without Proline-Arginine-Arginine-Alanine Variants in Coronavirus Disease 2019 Patients
    Yik Chun Wong, Siu-Ying Lau, Kelvin Kai‐Wang To, Bobo Wing-Yee Mok, Xin Li, Pui Wang, Shaofeng Deng, Kin Fai Woo, Zhenglong Du, Cun Li et al. · 2020 · Clinical Infectious Diseases
  46. Molecular Insights into the Thrombotic and Microvascular Injury in Placental Endothelium of Women with Mild or Severe COVID-19
    Arturo Flores Pliego, Jael Miranda, Sara Vega-Torreblanca, María Yolotzín Valdespino-Vázquez, Addy Cecilia Helguera‐Repetto, Aurora Espejel-Núñez, Héctor Jesús Borboa-Olivares, Salvador Espino y Sosa, Paloma Mateu-Rogell, Moisés León‐Juárez et al. · 2021 · Cells
  47. BNT162b2 Vaccination Effectively Combats the Rapid Rise of SARS-CoV-2 Variant B.1.1.7 in High Risk Populations in Israel
    Ariel Munitz, Matan Yechezkel, Yoav Dickstein, Dan Yamin, Motti Gerlic · 2021 · Cell Reports Medicine
  48. Molecular biology of the SARs‐CoV‐2 spike protein: A review of current knowledge
    Chaogeng Zhu, Guiyun He, Qinqin Yin, Lin Zeng, Xiangli Ye, Yongzhong Shi, Wei Xu · 2021 · Journal of Medical Virology
  49. Rapid Increase of SARS-CoV-2 Variant B.1.1.7 Detected in Sewage Samples from England between October 2020 and January 2021
    Thomas Wilton, Erika Bujáki, Dimitra Klapsa, Manasi Majumdar, Maria Cristina Fleischmann Alves Zambon, Martin Fritzsche, Ryan Mate, Javier Escalada-San Martín · 2021 · mSystems
  50. Implications of testicular ACE2 and the renin–angiotensin system for SARS-CoV-2 on testis function
    R. Clayton Edenfield, Charles A. Easley · 2021 · Nature Reviews Urology
  51. Nucleocapsid protein of SARS‐CoV‐2 is a potential target for developing new generation of vaccine
    Weixu Feng, Yunru Xiang, Lianpeng Wu, Zhuo Chen, Qingfeng Li, Jun Chen, Yanru Guo, Dandan Xia, Na Chen, Lifang Zhang et al. · 2022 · Journal of Clinical Laboratory Analysis
  52. SARS-CoV-2 evolution influences GBP and IFITM sensitivity
    Dejan Mesner, Ann‐Kathrin Reuschl, Matthew V. X. Whelan, Taylor Bronzovich, Tafhima Haider, Lucy Thorne, Roberta Ragazzini, Paola Bonfanti, Greg J. Towers, Clare L. Jolly · 2023 · Proceedings of the National Academy of Sciences
  53. Roles of the polybasic furin cleavage site of spike protein in SARS‐CoV‐2 replication, pathogenesis, and host immune responses and vaccination
    Md. Golzar Hossain, Yan‐Dong Tang, Sharmin Akter, Chunfu Zheng · 2021 · Journal of Medical Virology
  54. Covid-19: virology, variants, and vaccines
    Megan Young, Harry Crook, Janet T. Scott, Paul Edison · 2022 · BMJ Medicine
  55. SARS-CoV-2 spike N-terminal domain modulates TMPRSS2-dependent viral entry and fusogenicity
    Bo Meng, Rawlings P. Datir, Jinwook Choi, Stephen G. Baker, Gordon Dougan, Christoph Hess, Nathalie Kingston, Paul J. Lehner, Paul Lyons, Nicholas J. Matheson et al. · 2022 · Cell Reports
  56. Betacoronavirus Assembly: Clues and Perspectives for Elucidating SARS-CoV-2 Particle Formation and Egress
    David Bracquemond, Delphine M. Muriaux · 2021 · mBio
  57. Positive selection within the genomes of SARS-CoV-2 and other Coronaviruses independent of impact on protein function
    Alejandro Berrío, Valerie Gartner, Gregory A. Wray · 2020 · PeerJ
  58. Human-Based Advanced in vitro Approaches to Investigate Lung Fibrosis and Pulmonary Effects of COVID-19
    Mirjam Kiener, Nuria Roldán, Carlos Machahua, Arunima Sengupta, Thomas Geiser, Olivier T. Guenat, Manuela Funke-Chambour, Nina Hobi, Marianna Kruithof‐de Julio · 2021 · Frontiers in Medicine
  59. Emerging SARS-CoV-2 Variants Can Potentially Break Set Epidemiological Barriers in COVID-19
    Ashutosh Kumar, Rakesh Parashar, Sujeet Kumar, Muneeb A. Faiq, Chiman Kumari, Maheswari Kulandhasamy, Ravi Kant Narayan, Rakesh K. Jha, Himanshu Narayan Singh, Pranav Prasoon et al. · 2021 · Journal of Medical Virology
  60. A Newly Engineered A549 Cell Line Expressing ACE2 and TMPRSS2 Is Highly Permissive to SARS-CoV-2, Including the Delta and Omicron Variants
    Ching‐Wen Chang, Krishna Mohan Parsi, Mohan Somasundaran, Emma Vanderleeden, John Cruz, Alyssa Cousineau, Ping Liu, Qi Li, Yang Wang, René Maehr et al. · 2022 · Viruses
  61. An antibody from single human V H -rearranging mouse neutralizes all SARS-CoV-2 variants through BA.5 by inhibiting membrane fusion
    Sai Luo, Jun Zhang, Alex J.B. Kreutzberger, Amanda Eaton, Robert J. Edwards, Changbin Jing, Hai‐Qiang Dai, Gregory D. Sempowski, Kenneth D. Cronin, Robert Parks et al. · 2022 · Science Immunology
  62. A systems immunology study comparing innate and adaptive immune responses in adults to COVID-19 mRNA and adenovirus vectored vaccines
    Feargal J. Ryan, Todd S. Norton, Conor McCafferty, Stephen J. Blake, Natalie E. Stevens, Jane James, Georgina L. Eden, Yee C. Tee, Saoirse C. Benson, Makutiro Ghislain Masavuli et al. · 2023 · Cell Reports Medicine
  63. Lineage-specific pathogenicity, immune evasion, and virological features of SARS-CoV-2 BA.2.86/JN.1 and EG.5.1/HK.3
    Yuanchen Liu, Xiaoyu Zhao, Jialu Shi, Yajie Wang, Huan Liu, Ye‐Fan Hu, Bingjie Hu, Huiping Shuai, Terrence Tsz‐Tai Yuen, Yue Chai et al. · 2024 · Nature Communications
  64. Why All the Fury over Furin?
    Essam Eldin A. Osman, Alnawaz Rehemtulla, Nouri Neamati · 2021 · Journal of Medicinal Chemistry
  65. S-acylation of SARS-CoV-2 spike protein: Mechanistic dissection, in vitro reconstitution and role in viral infectivity
    Robbins Puthenveetil, Cheng Man Lun, R. Elliot Murphy, Liam B. Healy, Géraldine Vilmen, Eric T. Christenson, Eric O. Freed, Anirban Banerjee · 2021 · Journal of Biological Chemistry
  66. Pharmacological features, health benefits and clinical implications of honokiol
    Khatoon, Fatima, Ali, Sabeeha, Kumar, Vijay, Elasbali, Abdelbaset Mohamed, Alhassan, Hassan H., Alharethi, Salem Hussain, Islam, Asimul, Hassan, Md. Imtaiyaz · 2023 · Journal of Biomolecular Structure and Dynamics
  67. Role of Endolysosomes in Severe Acute Respiratory Syndrome Coronavirus-2 Infection and Coronavirus Disease 2019 Pathogenesis: Implications for Potential Treatments
    Nabab Khan, Xuesong Chen, Jonathan D. Geiger · 2020 · Frontiers in Pharmacology
  68. Positively Charged Electroceutical Spun Chitosan Nanofibers Can Protect Health Care Providers From COVID-19 Infection: An Opinion
    Rania M. Hathout, Dina Hamada Kassem · 2020 · Frontiers in Bioengineering and Biotechnology
  69. The Central Role of Fibrinolytic Response in COVID-19—A Hematologist’s Perspective
    Hau C. Kwaan, Paul F. Lindholm · 2021 · International Journal of Molecular Sciences
  70. Nano-Enabled COVID-19 Vaccines: Meeting the Challenges of Durable Antibody Plus Cellular Immunity and Immune Escape
    André E. Nel, Jeff F. Miller · 2021 · ACS Nano
  71. Impact of new variants on SARS-CoV-2 infectivity and neutralization: A molecular assessment of the alterations in the spike-host protein interactions
    M. H. Cheng, James M. Krieger, Anupam Banerjee, Yufei Xiang, B. Kaynak, Yi Shi, M. Arditi, I. Bahar · 2022 · iScience
  72. Potential Anti-SARS-CoV-2 Therapeutics That Target the Post-Entry Stages of the Viral Life Cycle: A Comprehensive Review
    Rami A. Al‐Horani, Srabani Kar · 2020 · Viruses
  73. Rapid SARS-CoV-2 Adaptation to Available Cellular Proteases
    M. Zeeshan Chaudhry, Kathrin Eschke, Markus Hoffmann, Martina Grashoff, Leila Abassi, Yeonsu Kim, Linda Brunotte, Stephan Ludwig, Andrea Kröger, Frank Klawonn et al. · 2022 · Journal of Virology
  74. A call for an independent inquiry into the origin of the SARS-CoV-2 virus
    Neil L. Harrison, Jeffrey David Sachs · 2022 · Proceedings of the National Academy of Sciences
  75. Structural Basis of SARS-CoV-2– and SARS-CoV–Receptor Binding and Small-Molecule Blockers as Potential Therapeutics
    Hariharan Sivaraman, Shi Yin Er, Yeu Khai Choong, Edem Gavor, Jayaraman Sivaraman · 2020 · The Annual Review of Pharmacology and Toxicology
  76. Janus sword actions of chloroquine and hydroxychloroquine against COVID-19
    Xuesong Chen, Jonathan D. Geiger · 2020 · Cellular Signalling
  77. A Crisp(r) New Perspective on SARS-CoV-2 Biology
    Adam L. Bailey, Michael Diamond · 2020 · Cell
  78. Epigenetic mechanisms influencing COVID-19
    Rwik Sen, Michael R. Garbati, Kevin F. Bryant, Yanan Lu · 2021 · Genome
  79. Epitope profiling reveals binding signatures of SARS-CoV-2 immune response in natural infection and cross-reactivity with endemic human CoVs
    Caitlin I. Stoddard, Jared Galloway, Helen Y. Chu, Mackenzie M. Shipley, Kevin Sung, Hannah L. Itell, Caitlin R. Wolf, Jennifer K. Logue, Ariana Magedson, Meghan E. Garrett et al. · 2021 · Cell Reports
  80. Increased mortality of COVID-19 infected diabetes patients: role of furin proteases
    Senthil Kumar Ganesan, Purushothaman Venkatratnam, Jaideep Mahendra, Nalini Devarajan · 2020 · International Journal of Obesity
  81. SARS-CoV-2 Spike Furin Cleavage Site and S2′ Basic Residues Modulate the Entry Process in a Host Cell-Dependent Manner
    Muriel Lavie, Jean Dubuisson, Sandrine Belouzard · 2022 · Journal of Virology
  82. Human iPSC-Based Modeling of Central Nerve System Disorders for Drug Discovery
    Qian Lu, Julia TCW · 2021 · International Journal of Molecular Sciences
  83. SARS-CoV-2 Entry Related Viral and Host Genetic Variations: Implications on COVID-19 Severity, Immune Escape, and Infectivity
    Szu‐Wei Huang, Sheng‐Fan Wang · 2021 · International Journal of Molecular Sciences
  84. Genetic variability in COVID-19-related genes in the Brazilian population
    Rodrigo Secolin, Tânia Kawasaki de Araujo, Marina C. Gonsales, Cristiane S. Rocha, Michel Satya Naslavsky, Luiz Armando De Marco, Maria Aparecida Camargos Bicalho, Vinícius de Lima Vazquez, Mayana Zatz, Wilson A. Silva et al. · 2021 · Human Genome Variation
  85. Neuropilin 1: A Novel Entry Factor for SARS-CoV-2 Infection and a Potential Therapeutic Target
    Endeshaw Chekol Abebe, Teklie Mengie Ayele, Zelalem Tilahun Muche, Tadesse Asmamaw Dejenie · 2021 · Biologics
  86. Safety and Efficacy of Combined Intramuscular/Intranasal RAZI-COV PARS Vaccine Candidate Against SARS-CoV-2: A Preclinical Study in Several Animal Models
    Seyed Reza Banihashemi, Ali Es‐haghi, Mohammad Hossein Fallah Mehrabadi, Mojtaba Noofeli, Ali Rezaei Mokarram, Alireza Ranjbar, Μ. D. Salman, Monireh Hajimoradi, Seyad Hossein Razaz, Maryam Taghdiri et al. · 2022 · Frontiers in Immunology
  87. Identification of cross-reactive CD8+ T cell receptors with high functional avidity to a SARS-CoV-2 immunodominant epitope and its natural mutant variants
    Chao Hu, M. Shen, Xiao-Jian Han, Qian Chen, Luo Li, Si-Yin Chen, Jing Zhang, Feng-xia Gao, Wen Wang, Ying-Ming Wang et al. · 2020 · bioRxiv
  88. Cancer and COVID-19: Why are cancer patients more susceptible to COVID-19?
    Saptarshi Sinha, Chanakya Nath Kundu · 2021 · Medical Oncology
  89. Cooperative multivalent receptor binding promotes exposure of the SARS-CoV-2 fusion machinery core
    Alexander J. Pak, Alvin Yu, Zunlong Ke, John A. G. Briggs, Gregory A. Voth · 2022 · Nature Communications
  90. Mechanism and evolution of human ACE2 binding by SARS-CoV-2 spike
    Antoni G. Wrobel · 2023 · Current Opinion in Structural Biology
  91. Cryo-electron Microscopy Structure of S-Trimer, a Subunit Vaccine Candidate for COVID-19
    Jiahao Ma, Danmei Su, Yinyan Sun, Xueqin Huang, Ying Shi Liang, Linqiang Fang, Yan Ma, Wenhui Li, Peng Liang, Sanduo Zheng · 2021 · Journal of Virology
  92. The folate antagonist methotrexate diminishes replication of the coronavirus SARS-CoV-2 and enhances the antiviral efficacy of remdesivir in cell culture models
    Kim M. Stegmann, Antje Dickmanns, Sabrina Gerber, Vella Nikolova, Luisa Klemke, Valentina Manzini, Denise Schlösser, Cathrin Bierwirth, Julia Freund, Maren Sitte et al. · 2021 · Virus Research
  93. Coronavirus disease 2019 (COVID‐19) update: From metabolic reprogramming to immunometabolism
    Mohammad Rudiansyah, Saade Abdalkareem Jasim, Zeinab Gol Mohammad pour, Sara Sohrabi Athar, Ali Salimi Jeda, Rumi Iqbal Doewes, Abduladheem Turki Jalil, Dmitry Olegovich Bokov, Yasser Fakri Mustafa, Mina Noroozbeygi et al. · 2022 · Journal of Medical Virology
  94. Metalloproteinase-Dependent and TMPRSS2-Independent Cell Surface Entry Pathway of SARS-CoV-2 Requires the Furin Cleavage Site and the S2 Domain of Spike Protein
    Mizuki Yamamoto, Jin Gohda, Ayako Kobayashi, Keiko Tomita, Youko Hirayama, Naohiko Koshikawa, Motoharu Seiki, Kentaro Semba, Tetsu Akiyama, Yasushi Kawaguchi et al. · 2022 · mBio
  95. Rapalogs downmodulate intrinsic immunity and promote cell entry of SARS-CoV-2
    Guoli Shi, Abhilash I. Chiramel, Tiansheng Li, Kin Kui Lai, Adam D. Kenney, Ashley Zani, Adrian C. Eddy, Saliha Majdoul, Lizhi Zhang, Tirhas Dempsey et al. · 2022 · Journal of Clinical Investigation
  96. The Genetic Variant of SARS-CoV-2: Would it matter for Controlling the Devastating Pandemic?
    Shuxin Guo, Kefang Liu, Jun Zheng · 2021 · International Journal of Biological Sciences
  97. Spike protein of SARS-CoV-2 variants: a brief review and practical implications
    Kattlyn Laryssa Candido, Caio Ricardo Eich, Luciana Oliveira de Fariña, Marina Kimiko Kadowaki, José Luis da Conceição Silva, Alexandre Maller, Rita de Cássia Garcia Simão · 2022 · Brazilian Journal of Microbiology
  98. Genome-wide CRISPR screens identify GATA6 as a proviral host factor for SARS-CoV-2 via modulation of ACE2
    Ma’ayan Israeli, Yaara Finkel, Yfat Yahalom-Ronen, Nir Paran, Theodor Chitlaru, Ofir Israeli, Inbar Cohen-Gihon, Moshe Aftalion, Reut Falach, Shahar Rotem et al. · 2022 · Nature Communications
  99. ABO blood group and link to COVID-19: A comprehensive review of the reported associations and their possible underlying mechanisms
    Eric Petterson Viana Pereira, Stela Mirla da Silva Felipe, Raquel Martins de Freitas, Valdevane Rocha Araújo, Paula Matias Soares, Jannison Karlly Cavalcante Ribeiro, Luiz Henrique Dos Santos, Juliana Osório Alves, Natália do Vale Canabrava, Maurício Fraga van Tilburg et al. · 2022 · Microbial Pathogenesis
  100. Novel Drugs Targeting the SARS-CoV-2/COVID-19 Machinery
    Ariane Sternberg, Dwight L. McKee, Cord Naujokat · 2020 · Current Topics in Medicinal Chemistry